FNY Partners Fund’s Kyntra Bio KYNB Stock Holding History

FNY Partners Fund’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12	Closed	-$7K	–	761
2017 Q1	$7K	Buy	+12	New	+$7.31K	﹤0.01%	1148

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

FNY Partners Fund's KYNB Position: Q2 2017 in Review

FNY Partners Fund sold out of Kyntra Bio (KYNB) in Q2 2017, closing a stake of 12 shares — an estimated $7K sold.

FNY Partners Fund first reported a position in KYNB in Q1 2017 and held it in 1 quarter. The position peaked at $7K in Q1 2017. 151 funds tracked by Wall St. Rank hold KYNB as of Q2 2017.

FNY Partners Fund reported no remaining Kyntra Bio position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 12 Kyntra Bio shares in Q2 2017, an estimated $7K.
FNY Partners Fund first reported a position in Kyntra Bio in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Kyntra Bio position peaked at $7K in Q1 2017.
151 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.